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Adam Austin
Mentor – Dr. James Tung
Nevada Cancer Institute
Expression of an alternate splice form of Bmi-1 in multiple myeloma
The concept of “tumor stem cells” has garnered much attention in the last few
years. Tumor stem cells are believed to exist among a heterogeneous group of
cells that constitute a tumor. These tumor stem cells often express genes that
are important for stem cell function, cell division, and maintenance of pluripotent
state in stem cells. Stem cell or stem cell maintenance genes such as SALL 4
and Bmi-1 are often seen in these cancer cells and contribute to self-renewing
divisions and cancer cell survival. In particular, high expression of Bmi-1 (B
lymphoma mouse Moloney leukemia virus insertion region), a member of the
polycomb family of transcription factors, is often associated with poor prognosis
in cancers.
Our laboratory has shown the existence of an alternatively spliced Bmi-1 RNA
and protein in multiple myeloma cells. The purpose of this research project is to
understand the effect of an alternate splice form of Bmi-1 protein on cell cycle
and apoptosis in multiple myeloma cells. To understand the effect of this
alternate Bmi-1 protein, I first compared the growth rate of different myeloma cell
lines and correlated that with the expression of the wild-type Bmi-1 and the
alternatively spliced Bmi-1 form. I performed time course experiments and
counted the cell numbers in each cell line at various time points. My results
show that the myeloma cell lines, which highly express the alternate form of Bmi1, grew faster than the myeloma cell lines, which mostly express the wild-type
form of Bmi-1. Currently I am performing RT-PCR and western blot analysis to
confirm the existence of the alternatively spliced Bmi-1 protein. I plan to isolate
and sequence the alternatively spliced form of Bmi-1. I also plan to determine the
effect of knocking-down Bmi-1 expression on cell cycle and apoptosis by
incorporating inducible shRNA viral constructs targeted against Bmi-1 RNA in
myeloma cells.

15

16

